Nurse Practitioner, Family · Nashville, TN
NPI
1518380187
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2801 Charlotte Ave
Nashville, TN, 37209
Phone (615) 250-9227
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
10,199 services
Medicare patients, 2024
497
Average age 74
Drug cost, 2024
$345K
847 prescriptions
Company payments, 2025
$7,305
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Woods was code J0897 (injection, denosumab, 1 mg), 1,320 times for 12 patients. In total Jeffrey S Woods billed 10,199 services in 48 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,320 | 12 | $20.22 | $27K |
| 99213 Office E&M - Established | Office | 556 | 386 | $47.31 | $26K |
| 84403 Clinical Chemistry | Office | 192 | 107 | $24.81 | $4,763 |
| 84270 Clinical Chemistry | Office | 180 | 101 | $20.86 | $3,756 |
| 82670 Clinical Chemistry | Office | 179 | 100 | $26.82 | $4,800 |
| 84410 Clinical Chemistry | Office | 179 | 100 | $49.47 | $8,855 |
| 82040 Clinical Chemistry | Office | 175 | 98 | $4.75 | $831 |
| 99214 Office E&M - Established | Office | 168 | 151 | $66.07 | $11K |
| 36415 Venipuncture Blood Collection | Office | 151 | 112 | $8.49 | $1,282 |
| 85014 Blood Count | Office | 138 | 82 | $2.28 | $314 |
| 84153 Clinical Chemistry | Office | 110 | 89 | $17.73 | $1,950 |
| 11980 Skin | Office | 88 | 32 | $53.67 | $4,723 |
| J3490 Unclassified drugs | Office | 64 | 26 | $514.59 | $33K |
| 96372 Injection Administration | Office | 54 | 20 | $7.76 | $419 |
| 85025 Blood Count | Office | 36 | 24 | $7.40 | $266 |
By year: 2022 $277K for 14,991 services; 2023 $265K for 14,594 services; 2024 $202K for 10,199 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84403 Clinical Chemistry | 192 | 107 | $24.81 | $4,763 |
| 84270 Clinical Chemistry | 180 | 101 | $20.86 | $3,756 |
| 82670 Clinical Chemistry | 179 | 100 | $26.82 | $4,800 |
| 84410 Clinical Chemistry | 179 | 100 | $49.47 | $8,855 |
| 82040 Clinical Chemistry | 175 | 98 | $4.75 | $831 |
| 36415 Venipuncture Blood Collection | 151 | 112 | $8.49 | $1,282 |
| 85014 Blood Count | 138 | 82 | $2.28 | $314 |
| 84153 Clinical Chemistry | 110 | 89 | $17.73 | $1,950 |
| 85025 Blood Count | 36 | 24 | $7.40 | $266 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Woods prescribed most often to Medicare patients was Testosterone Cypionate, with 374 prescriptions and refills. In total Jeffrey S Woods wrote 847 Medicare prescriptions that cost $345K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Testosterone Cypionate Generic | 374 | 539 | 85 | $16K |
| Tamsulosin Hcl Generic | 117 | 276 | 35 | $1,596 |
| Testosterone Generic | 63 | 93 | 20 | $15K |
| Anastrozole Generic | 40 | 76 | 15 | $94.68 |
| Finasteride Generic | 29 | 87 | 11 | $328 |
| Sildenafil Citrate Generic | 24 | 32 | Under 11 | $180 |
| Xiaflex Collagenase Clostridium Hist. | 19 | 22 | Under 11 | $239K |
| Xyosted Testosterone Enanthate | 16 | 16 | Under 11 | $9,467 |
| Myrbetriq Mirabegron | 15 | 27 | Under 11 | $12K |
| Gemtesa Vibegron | 13 | 31 | Under 11 | $14K |
| Silodosin Generic | 12 | 12 | Under 11 | $356 |
| Meloxicam Generic | 12 | 20 | Under 11 | $36.33 |
Brand drugs: - claims; generic drugs: 755 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Woods $7,305 ($7,305 in general payments such as food, travel and fees) from 26 companies. The largest payer was Endo USA, Inc. with $3,834.
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 31 | $3,834 |
| Tolmar, Inc. | 14 | $652 |
| Sumitomo Pharma America, Inc. 4506.T | 22 | $473 |
| Antares Pharma, Inc. | 24 | $441 |
| Janssen Biotech, Inc. JNJ | 12 | $409 |
| Valencia Technologies Corporation | 5 | $320 |
| Abbvie Inc. ABBV | 7 | $211 |
| Astellas Pharma US Inc 4503.T | 8 | $165 |
| Boston Scientific Corporation BSX | 4 | $145 |
| SRS Medical Systems, Inc. | 1 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.